imipramine has been researched along with Anxiety Disorders in 195 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This naturalistic study examined the treatment response to imipramine of 60 patients who had panic disorder or agoraphobia with panic attacks." | 9.06 | A naturalistic study of imipramine in panic disorder and agoraphobia. ( Aronson, TA, 1987) |
| "At the end of a two-week single-blind placebo baseline, 43 patients with a diagnosis of panic disorder with agoraphobia without significant dysphoria-depression and with moderate to severe panic and phobic symptoms were assigned to, and 32 of them completed, a placebo-controlled (n = 7) dose-response study with three weight-adjusted imipramine hydrochloride dosages: 0." | 9.06 | Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings. ( Mavissakalian, MR; Perel, JM, 1989) |
| "Thirty-eight patients who had panic disorder with agoraphobia completed 8 weeks of treatment with imipramine followed by 8 weeks of treatment with imipramine combined with behavior therapy consisting of self-directed exposure." | 7.68 | Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia. ( Mavissakalian, M, 1990) |
| "Two women with panic disorder who continued to be symptomatic during pregnancy were successfully treated with low doses of imipramine." | 7.68 | Imipramine treatment of panic disorder during pregnancy. ( DeVane, CL; Ware, MR, 1990) |
| "The response to treatment with imipramine or clonazepam was evaluated in patients with panic disorder." | 7.68 | [Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam]. ( Carreira, I; Casique, M; Lima, L; Morales, M; Silva, C, 1992) |
| "High-affinity binding of 3H-imipramine was analyzed in platelet membranes from patients with chronic psychogenic pain." | 7.67 | Platelet 3H-imipramine binding in psychogenic pain patients. ( Bech, P; Hansen, HJ; Langemark, M; Loldrup, D; Mellerup, ET; Plenge, P, 1988) |
| "Alprazolam therapy was effective and well tolerated at a mean daily dose of 5." | 6.67 | Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993) |
| "This study aimed to compare the effectiveness of mirtazapine and imipramine on not only the distressing symptoms of cancer patients such as pain, nausea, vomiting, appetite loss, and sleep disturbances but also depressive and anxiety symptoms." | 5.13 | Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. ( Akbiyik, DI; Alkis, N; Cankurtaran, ES; Ozalp, E; Soygur, H; Turhan, L, 2008) |
| "To examine the effect of treatment on lactate-induced anxiety in a controlled study, we infused 44 panic disorder patients with lactate and placebo before and after eight weeks of double-blind treatment with imipramine, diazepam, or placebo." | 5.07 | Lactate-induced anxiety after imipramine and diazepam treatment. ( Balon, R; Berchou, R; Lycaki, H; Pohl, R, 1994) |
| "This naturalistic study examined the treatment response to imipramine of 60 patients who had panic disorder or agoraphobia with panic attacks." | 5.06 | A naturalistic study of imipramine in panic disorder and agoraphobia. ( Aronson, TA, 1987) |
| "At the end of a two-week single-blind placebo baseline, 43 patients with a diagnosis of panic disorder with agoraphobia without significant dysphoria-depression and with moderate to severe panic and phobic symptoms were assigned to, and 32 of them completed, a placebo-controlled (n = 7) dose-response study with three weight-adjusted imipramine hydrochloride dosages: 0." | 5.06 | Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings. ( Mavissakalian, MR; Perel, JM, 1989) |
| "Six subjects with the phobic-anxiety syndrome were treated in a controlled, crossover trial of clonidine hydrochloride v imipramine hydrochloride for periods of four weeks each." | 5.05 | Panic-induced elevation of plasma MHPG levels in phobic-anxious patients. Effects of clonidine and imipramine. ( Elsworth, JD; Ko, GN; Leigh, H; Redmond, DE; Rifkin, BG; Roth, RH, 1983) |
| "The recognition of the efficacy of imipramine for treating panic disorder and its complications has had major implications for clinical practice, diagnostic classification, theoretic understanding, and research strategies in the anxiety disorders." | 5.05 | Imipramine in the treatment of panic disorder and its complications. ( Liebowitz, MR, 1985) |
| " It should be noted that although imipramine is efficient in both depressive disorder and separation anxiety, this does not implicate a common physiopathologic basis." | 4.78 | [Considerations on respective roles of anxiety and depressive disorders in children]. ( Coudert, AJ; Jalenques, I, 1991) |
| " Many double-blind controlled studies have shown that imipramine effectively ameliorates panic attacks and agoraphobia." | 4.77 | Panic disorder: response to sodium lactate and treatment with antidepressants. ( Rifkin, A; Siris, SG, 1985) |
| " Among the more important recent discoveries are the efficacy of the tricyclic antidepressants for panic disorder and agoraphobia with panic attacks; the use of the monoamine oxidase inhibitors for the above disorders and for atypical depression and hysteroid dysphoria; the use of propranolol for anxiety disorders and for uncontrollable violent outbursts; the antianxiety and antipanic effects of clonidine; and the usefulness of lithium in treating schizophrenia and schizoaffective disorder and for emotionally unstable character disorders." | 4.76 | Newer uses for older psychotropic medications. ( Liebowitz, MR, 1982) |
| "Alprazolam has antidepressant activity and has been shown to be similar in efficacy to imipramine in the treatment of unipolar depression." | 3.75 | Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. ( Brogden, RN; Dawson, GW; Jue, SG, 1984) |
| "The psychopharmacological treatment of separation anxiety is reviewed, with special emphasis on the use of tricyclic antidepressants." | 3.75 | Relationship between separation anxiety and panic and agoraphobic disorders. ( Gittelman, R; Klein, DF, 1984) |
| "Trazodone has been reported to be of value in tremors and chronic alcoholism." | 3.75 | Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1981) |
| "We measured platelet [3H]imipramine and [3H]paroxetine binding in patients with major depression (n = 11), dysthymia (n = 9), generalized anxiety (n = 18) and panic disorder (n = 10), and in healthy controls (n = 13)." | 3.69 | Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. ( Bernier, B; Iny, LJ; Luthe, L; Meaney, MJ; Nair, NP; Pecknold, J; Suranyi-Cadotte, BE, 1994) |
| "Thirty-eight patients who had panic disorder with agoraphobia completed 8 weeks of treatment with imipramine followed by 8 weeks of treatment with imipramine combined with behavior therapy consisting of self-directed exposure." | 3.68 | Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia. ( Mavissakalian, M, 1990) |
| "The response to treatment with imipramine or clonazepam was evaluated in patients with panic disorder." | 3.68 | [Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam]. ( Carreira, I; Casique, M; Lima, L; Morales, M; Silva, C, 1992) |
| "Two women with panic disorder who continued to be symptomatic during pregnancy were successfully treated with low doses of imipramine." | 3.68 | Imipramine treatment of panic disorder during pregnancy. ( DeVane, CL; Ware, MR, 1990) |
| "Platelet 3H-imipramine binding was investigated in 15 normal subjects, 17 patients with major depressive disorder and 43 patients with panic disorder, to further study the relationship between depressive and anxiety disorders." | 3.67 | Platelet imipramine binding in patients with panic disorder and major familial depression. ( Chang, H; Fleury, D; Koszychi, D; Nair, NP; Pecknold, JC; Quirion, R; Suranyi-Cadotte, BE, 1987) |
| " Imipramine hydrochloride, which has complex effects on noradrenergic function in animals, is effective in patients with agoraphobia and panic disorder." | 3.67 | Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. ( Charney, DS; Heninger, GR, 1985) |
| "High-affinity binding of 3H-imipramine was analyzed in platelet membranes from patients with chronic psychogenic pain." | 3.67 | Platelet 3H-imipramine binding in psychogenic pain patients. ( Bech, P; Hansen, HJ; Langemark, M; Loldrup, D; Mellerup, ET; Plenge, P, 1988) |
| "We compared 3H-imipramine binding in 10 major depressives with that in 29 healthy volunteers, 13 patients with panic disorder, 9 patients with bulimia, 9 suicide attempters, and 6 schizophrenic patients." | 3.67 | Lack of specificity of reduced platelet imipramine binding in different psychiatric conditions. ( Akiskal, HS; Cassano, GB; Marazziti, D; Placidi, GF, 1989) |
| "Ten cases are presented--two in detail--in which clonazepam was used successfully in patients with treatment-resistant panic disorder with or without agoraphobia." | 3.67 | Successful use of clonazepam in patients with treatment-resistant panic disorder. ( Rosenbaum, JF; Tesar, GE, 1986) |
| "Reports that imipramine and phenelzine prevent panic attacks in agoraphobia suggest the possibility that agoraphobia and/or panic disorder might be a clinical manifestation of underlying depression." | 3.66 | The dexamethasone suppression test in panic disorder and agoraphobia. ( Cameron, OG; Curtis, GC; Nesse, RM, 1982) |
| "imipramine." | 2.70 | Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. ( Davis, S; Friedman, ES; Harrison, W; Hirschfeld, RM; Keller, M; Koran, LM; Rush, J; Russell, JM, 2001) |
| "We examine whether baseline anxiety or insomnia symptoms (1) show differential response to fluoxetine or imipramine or (2) predict differences between drugs in overall clinical response or likelihood of medication discontinuation." | 2.69 | Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine. ( Grothaus, L; Heiligenstein, JH; Katon, W; Revicki, D; Simon, GE, 1998) |
| "Nefazodone treatment was broadly effective across several measures of anxiety symptoms (HAM-D, HAM-A and SCL rating scales) in relieving depression-associated anxiety." | 2.68 | The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings. ( Zajecka, JM, 1996) |
| "Buspirone was compared with imipramine and placebo in the treatment of panic disorder in an 8-week, double-blind controlled study of 52 randomly assigned patients." | 2.67 | Is buspirone effective for panic disorder? ( Raj, AB; Sheehan, DV; Sheehan, KH; Soto, S, 1990) |
| "Alprazolam was more effective than imipramine and placebo on anticipatory anxiety and phobic symptoms." | 2.67 | Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. ( Andersch, S; Bech, P; Bruun-Hansen, J; Hanson, L; Kullingsjö, H; Lorentzen, K; Mellergård, M; Ottosson, JO; Rasmussen, S; Rosenberg, NK, 1991) |
| "Alprazolam therapy was effective and well tolerated at a mean daily dose of 5." | 2.67 | Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993) |
| "The alprazolam effects were apparent by week 1; the imipramine effects by week 4." | 2.67 | Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. ( Agras, WS; Clark, D; Ehlers, A; Hayward, C; King, R; Maddock, R; Margraf, J; Roth, WT; Taylor, CB, 1990) |
| "Imipramine either was not superior on these measures or took longer to show a significant difference." | 2.67 | Paroxetine in major depression: a double-blind trial with imipramine and placebo. ( Cohn, JB; Wilcox, CS, 1992) |
| "Imipramine was superior to placebo in lowering panic and avoidance at both postbaseline time points." | 2.66 | Panic and avoidance in agoraphobia. Application of path analysis to treatment studies. ( Cohen, P; Klein, DF; Ross, DC, 1987) |
| " In a 6-week, double-blind, parallel-design study with flexible dosage scheduling, the authors compared the effects of alprazolam with those of imipramine in 60 patients who had generalized anxiety disorder." | 2.66 | Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. ( Hoehn-Saric, R; McLeod, DR; Zimmerli, WD, 1988) |
| "Phenelzine was widely superior to placebo and also showed superiority to imipramine." | 2.66 | Antidepressant specificity in atypical depression. ( Goetz, DM; Harrison, WM; Klein, DF; Liebowitz, MR; Markowitz, JS; McGrath, PJ; Quitkin, FM; Rabkin, JG; Stewart, JW; Tricamo, E, 1988) |
| "Phenelzine was found to be superior to imipramine and placebo." | 2.66 | Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. ( Harrison, WM; Klein, DF; Liebowitz, MR; Markowitz, JS; McGrath, PJ; Quitkin, FM; Rabkin, JG; Stewart, JW; Tricamo, E; Wager, SG, 1988) |
| "Imipramine was superior to placebo on many of the outcome measures." | 2.66 | The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report. ( Raj, AB; Sheehan, DV; Sheehan, KH; Soto, S, 1988) |
| "Phenelzine was superior to imipramine on the interpersonal sensitivity and paranoia factors of the 90-item Hopkins Symptom Checklist, with trends toward superiority on several other measures, while imipramine was not differentially superior on any measure." | 2.65 | Phenelzine v imipramine in atypical depression. A preliminary report. ( Harrison, W; Klein, DF; Liebowitz, MR; Markowitz, JS; McGrath, PJ; Quitkin, FM; Rabkin, J; Stewart, JW; Tricamo, E, 1984) |
| "Buspirone has demonstrated anxiolytic benefits but, like benzodiazepines, shows negligible antidepressant action." | 2.42 | Treating generalized anxiety disorder. ( Gorman, JM, 2003) |
| " Dosing instructions for buspirone and guidelines for switching patients from benzodiazepines to buspirone are offered." | 2.40 | Strategies for treatment of generalized anxiety in the primary care setting. ( Rickels, K; Schweizer, E, 1997) |
| "Nefazodone was found to have an excellent safety profile and was well tolerated, with 5% of nefazodone patients prematurely discontinuing treatment for adverse experiences compared with 17% for imipramine and 5% for placebo treatment." | 2.39 | Response of anxiety and agitation symptoms during nefazodone treatment of major depression. ( Anton, SF; Fawcett, J; Marcus, RN; O'Brien, K; Schwiderski, U, 1995) |
| "It is important to understand both the kinetic and the dynamic implications of dosing TCAs and BZs in the elderly, for whom these drugs are frequently prescribed." | 2.37 | Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics. ( Cutler, NR; Narang, PK, 1984) |
| "Clomipramine has been found superior to placebo or other psychoactive drugs in 5 controlled studies." | 2.37 | Antidepressant drugs in anxiety disorders. ( Modigh, K, 1987) |
| "Global transient cerebral ischemia was performing with the four-vessels occlusion method." | 1.35 | Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances. ( Bantsiele, GB; Bentué-Ferrer, D; Bourin, M; Laviolle, B; Reymann, JM; Saïkali, S, 2009) |
| "Imipramine has been shown to reduce anxiety in patients with generalized anxiety disorder (GAD)." | 1.31 | Therapeutic effects of imipramine are counteracted by its metabolite, desipramine, in patients with generalized anxiety disorder. ( Clark, CM; Hoehn-Saric, R; Kowalski, PA; McLeod, DR; Porges, SW, 2000) |
| "Posttraumatic stress disorder (PTSD) is frequently associated with major depressive disorder, and antidepressants have been reported to ameliorate PTSD symptoms in some patients." | 1.29 | Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment. ( Abramovitz-Schnaider, P; Freudstein-Dan, A; Laor, N; Rehavi, M; Schujovitsky, A; Weizman, R; Wolmer, L, 1996) |
| "Doctors' prescription and dosing behaviour was investigated using data from 9 clinical trials in 550 patients treated with psychotropics." | 1.29 | Correct titration of non-drugs and some other methodological issues. ( Beneke, M; Fritze, J; Rasmus, W; Rød, IS, 1994) |
| "Treatment with imipramine hydrochloride decreased the number of sites, as measured with either ligand, in both patient groups and increased catecholamine levels in patients with panic attacks." | 1.27 | Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety. ( Cameron, OG; Curtis, GC; Hollingsworth, PJ; Nesse, RM; Smith, CB, 1984) |
| "A case is reported of a boy with Tourette's syndrome whose panic attacks were successfully treated with imipramine." | 1.27 | Imipramine treatment of panic disorder in a boy with Tourette's syndrome. ( Sverd, J, 1988) |
| "The myoclonus was reversible with the discontinuation of therapy but tended to persist if medication changes were not made." | 1.27 | Occurrence of myoclonus in patients treated with cyclic antidepressants. ( Garvey, MJ; Tollefson, GD, 1987) |
| "Desipramine was associated with a much higher frequency of jitteriness than was imipramine." | 1.27 | The jitteriness syndrome in panic disorder patients treated with antidepressants. ( Balon, R; Lycaki, H; Pohl, R; Yeragani, VK, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 110 (56.41) | 18.7374 |
| 1990's | 61 (31.28) | 18.2507 |
| 2000's | 18 (9.23) | 29.6817 |
| 2010's | 6 (3.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Rezende, VB | 1 |
| Rosa, DV | 1 |
| Comim, CM | 1 |
| Magno, LA | 1 |
| Rodrigues, AL | 1 |
| Vidigal, P | 1 |
| Jeromin, A | 1 |
| Quevedo, J | 1 |
| Romano-Silva, MA | 1 |
| Vogt, MA | 1 |
| Mallien, AS | 1 |
| Pfeiffer, N | 1 |
| Inta, I | 1 |
| Gass, P | 1 |
| Inta, D | 1 |
| Bantsiele, GB | 1 |
| Bentué-Ferrer, D | 1 |
| Saïkali, S | 1 |
| Laviolle, B | 1 |
| Bourin, M | 1 |
| Reymann, JM | 1 |
| Sukul, YR | 1 |
| Birkenhäger, TK | 1 |
| van den Broek, WW | 1 |
| Mulder, PG | 1 |
| Bruijn, JA | 1 |
| Wagner, KD | 1 |
| Preskorn, SH | 1 |
| Vicente, MA | 1 |
| Zangrossi, H | 1 |
| Tallerova, AV | 1 |
| Kovalenko, LP | 1 |
| Durnev, AD | 1 |
| Seredenin, SB | 1 |
| Layne, AE | 1 |
| Bernstein, GA | 3 |
| Egan, EA | 1 |
| Kushner, MG | 1 |
| Gorman, JM | 5 |
| DEMAY-LAULAN, M | 1 |
| DEMAY, J | 1 |
| JOSSE, G | 1 |
| LAVOINE, M | 1 |
| HAUSNER, M | 1 |
| DOLEZAL, V | 1 |
| LANCE, JW | 1 |
| CURRAN, DA | 1 |
| STRAKHOV, AP | 1 |
| TIMOFEEVA, AN | 1 |
| LIPSKAIA, LA | 1 |
| KLEIN, DF | 14 |
| SCHULZE, HA | 1 |
| NEUMANN, J | 1 |
| Heuzenroeder, L | 1 |
| Donnelly, M | 1 |
| Haby, MM | 1 |
| Mihalopoulos, C | 1 |
| Rossell, R | 1 |
| Carter, R | 1 |
| Andrews, G | 2 |
| Vos, T | 1 |
| Schmitt, R | 1 |
| Gazalle, FK | 1 |
| Lima, MS | 1 |
| Cunha, A | 1 |
| Souza, J | 1 |
| Kapczinski, F | 1 |
| Maia, CR | 1 |
| Rohde, LA | 1 |
| Stemmelin, J | 1 |
| Cohen, C | 1 |
| Terranova, JP | 1 |
| Lopez-Grancha, M | 1 |
| Pichat, P | 1 |
| Bergis, O | 1 |
| Decobert, M | 1 |
| Santucci, V | 1 |
| Françon, D | 1 |
| Alonso, R | 1 |
| Stahl, SM | 1 |
| Keane, P | 1 |
| Avenet, P | 1 |
| Scatton, B | 1 |
| le Fur, G | 1 |
| Griebel, G | 1 |
| Volkers, AC | 1 |
| Heerdink, ER | 1 |
| van Dijk, L | 1 |
| Cankurtaran, ES | 1 |
| Ozalp, E | 1 |
| Soygur, H | 1 |
| Akbiyik, DI | 1 |
| Turhan, L | 1 |
| Alkis, N | 1 |
| Cameron, OG | 3 |
| Smith, CB | 1 |
| Hollingsworth, PJ | 1 |
| Nesse, RM | 3 |
| Curtis, GC | 3 |
| Uhlenhuth, EH | 1 |
| Liebowitz, MR | 9 |
| Dawson, GW | 1 |
| Jue, SG | 1 |
| Brogden, RN | 2 |
| Garakani, H | 1 |
| Zitrin, CM | 1 |
| Pohl, R | 9 |
| Rainey, JM | 1 |
| Gershon, S | 1 |
| Gittelman, R | 1 |
| Quitkin, FM | 5 |
| Stewart, JW | 5 |
| McGrath, PJ | 5 |
| Harrison, W | 4 |
| Rabkin, J | 1 |
| Tricamo, E | 5 |
| Markowitz, JS | 4 |
| Rabkin, JG | 4 |
| Nies, A | 1 |
| Sternberg, DE | 1 |
| Cutler, NR | 1 |
| Narang, PK | 1 |
| Beaini, AY | 1 |
| Hindmarch, I | 1 |
| Snaith, RP | 1 |
| Van Winter, JT | 1 |
| Stickler, GB | 1 |
| Akiskal, HS | 2 |
| Arana, GW | 1 |
| Baldessarini, RJ | 1 |
| Barreira, PJ | 1 |
| Grant, B | 1 |
| Katon, W | 2 |
| Beitman, B | 1 |
| Breier, A | 1 |
| Ginsberg, EM | 1 |
| Charney, DS | 4 |
| Bueno, JA | 1 |
| Sabanes, F | 1 |
| Gascon, J | 1 |
| Gasto, C | 1 |
| Salamero, M | 1 |
| Friedman, MJ | 1 |
| Stolk, JM | 1 |
| Harris, PQ | 1 |
| Cooper, TB | 1 |
| Fyer, AJ | 2 |
| Dillon, D | 2 |
| Appleby, IL | 1 |
| Levy, G | 1 |
| Anderson, S | 1 |
| Levitt, M | 2 |
| Palij, M | 1 |
| Davies, SO | 2 |
| Nissen, G | 1 |
| Matuzas, W | 2 |
| Glass, RM | 1 |
| Burnstein, A | 1 |
| Ko, GN | 1 |
| Elsworth, JD | 1 |
| Roth, RH | 1 |
| Rifkin, BG | 1 |
| Leigh, H | 1 |
| Redmond, DE | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Davis, JM | 1 |
| Nasr, S | 1 |
| Spira, N | 1 |
| Vogel, C | 1 |
| Sheehan, DV | 6 |
| Pöldinger, W | 1 |
| Katerndahl, DA | 1 |
| Nurnberg, HG | 1 |
| Coccaro, EF | 1 |
| Colonna, L | 1 |
| Petit, M | 1 |
| Rifkin, A | 2 |
| Sovner, RD | 1 |
| Fawcett, J | 1 |
| Marcus, RN | 1 |
| Anton, SF | 1 |
| O'Brien, K | 1 |
| Schwiderski, U | 1 |
| Alpert, JE | 1 |
| Maddocks, A | 1 |
| Rosenbaum, JF | 2 |
| Fava, M | 1 |
| Beneke, M | 1 |
| Rasmus, W | 1 |
| Rød, IS | 1 |
| Fritze, J | 1 |
| Iny, LJ | 1 |
| Pecknold, J | 1 |
| Suranyi-Cadotte, BE | 2 |
| Bernier, B | 1 |
| Luthe, L | 1 |
| Nair, NP | 2 |
| Meaney, MJ | 1 |
| Perini, G | 1 |
| Zara, M | 1 |
| Cipriani, R | 1 |
| Carraro, C | 1 |
| Preti, A | 1 |
| Gava, F | 1 |
| Coghi, P | 1 |
| Peserico, A | 1 |
| Rickels, K | 5 |
| Downing, R | 2 |
| Schweizer, E | 3 |
| Hassman, H | 1 |
| Balon, R | 8 |
| Yeragani, VK | 7 |
| Ramesh, C | 3 |
| Feighner, JP | 1 |
| Cohn, JB | 2 |
| Fabre, LF | 1 |
| Fieve, RR | 1 |
| Mendels, J | 1 |
| Shrivastava, RK | 1 |
| Dunbar, GC | 1 |
| Weiss, S | 1 |
| Zavodnick, S | 1 |
| Delini-Stula, A | 1 |
| Mikkelsen, H | 1 |
| Angst, J | 1 |
| Zajecka, JM | 1 |
| Weizman, R | 1 |
| Laor, N | 1 |
| Schujovitsky, A | 1 |
| Wolmer, L | 1 |
| Abramovitz-Schnaider, P | 1 |
| Freudstein-Dan, A | 1 |
| Rehavi, M | 1 |
| Berchou, R | 1 |
| Lycaki, H | 2 |
| Wamboldt, MZ | 1 |
| Yancey, AG | 1 |
| Roesler, TA | 1 |
| Rocca, P | 1 |
| Fonzo, V | 1 |
| Scotta, M | 1 |
| Zanalda, E | 1 |
| Ravizza, L | 1 |
| Simon, GE | 1 |
| Heiligenstein, JH | 1 |
| Grothaus, L | 1 |
| Revicki, D | 1 |
| Bouwer, C | 1 |
| Stein, DJ | 1 |
| Montgomery, SA | 1 |
| Judge, R | 1 |
| DeMartinis, N | 1 |
| García-España, F | 1 |
| Greenblatt, DJ | 1 |
| Mandos, LA | 1 |
| Rynn, M | 1 |
| McLeod, DR | 4 |
| Hoehn-Saric, R | 4 |
| Porges, SW | 1 |
| Kowalski, PA | 1 |
| Clark, CM | 1 |
| Hektner, JM | 1 |
| Borchardt, CM | 2 |
| McMillan, MH | 1 |
| Russell, JM | 1 |
| Koran, LM | 1 |
| Rush, J | 1 |
| Hirschfeld, RM | 1 |
| Friedman, ES | 1 |
| Davis, S | 1 |
| Keller, M | 1 |
| Sontheimer, DL | 1 |
| Ables, AZ | 1 |
| Gupta, R | 1 |
| Gupta, N | 1 |
| Avasthi, A | 1 |
| de Kemp, EC | 1 |
| Moleman, P | 1 |
| Hoogduin, CA | 1 |
| Broekman, TG | 1 |
| Goedhart, A | 1 |
| Schaap, CP | 1 |
| van den Berg, PC | 1 |
| Sheinbein, ML | 1 |
| Wiggins, KM | 1 |
| McCann, UD | 1 |
| Ricaurte, GA | 1 |
| Lima, L | 1 |
| Carreira, I | 1 |
| Morales, M | 1 |
| Silva, C | 1 |
| Casique, M | 1 |
| Wilcox, CS | 1 |
| Jalenques, I | 1 |
| Coudert, AJ | 1 |
| Jack, E | 1 |
| Buller, R | 4 |
| Maier, W | 5 |
| Goldenberg, IM | 1 |
| Lavori, PW | 1 |
| Benkert, O | 2 |
| Rosenberg, R | 7 |
| Argyle, N | 2 |
| Roth, M | 1 |
| Brandon, S | 1 |
| Andersch, S | 1 |
| Rosenberg, NK | 4 |
| Kullingsjö, H | 1 |
| Ottosson, JO | 6 |
| Bech, P | 8 |
| Bruun-Hansen, J | 1 |
| Hanson, L | 1 |
| Lorentzen, K | 2 |
| Mellergård, M | 7 |
| Rasmussen, S | 1 |
| Beck, P | 1 |
| Warnock, JK | 1 |
| Sieg, K | 1 |
| Willsie, D | 1 |
| Stevenson, EK | 1 |
| Kestenbaum, T | 1 |
| Garland, EJ | 1 |
| Smith, DH | 1 |
| Clark, DB | 2 |
| Taylor, CB | 4 |
| Roth, WT | 4 |
| Hayward, C | 2 |
| Ehlers, A | 4 |
| Margraf, J | 4 |
| Agras, WS | 4 |
| Sheikh, J | 1 |
| Bartels, MG | 1 |
| Varley, CK | 1 |
| Mitchell, J | 1 |
| Stamm, SJ | 1 |
| Deltito, JA | 1 |
| Klerman, GL | 2 |
| Iruela, LM | 1 |
| Gilaberte, I | 1 |
| Oliveros, SC | 1 |
| Rojo, VI | 1 |
| Stokes, PE | 1 |
| Cox, BJ | 1 |
| Swinson, RP | 1 |
| Endler, NS | 1 |
| Zealberg, JJ | 1 |
| Lydiard, RB | 2 |
| Christie, S | 1 |
| Feder, R | 1 |
| Mattick, RP | 1 |
| Hadzi-Pavlovic, D | 1 |
| Christensen, H | 1 |
| Albus, M | 3 |
| Nutzinger, D | 1 |
| Shera, D | 2 |
| Woods, SW | 2 |
| Delgado, PL | 1 |
| Heninger, GR | 3 |
| Svebak, S | 1 |
| Cameron, A | 1 |
| Levander, S | 1 |
| King, R | 2 |
| Maddock, R | 1 |
| Clark, D | 1 |
| Wager, SG | 2 |
| Ocepek-Welikson, K | 1 |
| Nunes, E | 1 |
| Garfinkel, BD | 1 |
| Ware, MR | 1 |
| DeVane, CL | 1 |
| Tiller, JW | 1 |
| Zimmerli, WD | 3 |
| De Souza, EB | 1 |
| Oliver, LK | 1 |
| Lecrubier, Y | 1 |
| Hippius, H | 1 |
| Meiri, PC | 1 |
| Merlos, B | 1 |
| Stein, MB | 1 |
| Uhde, TW | 1 |
| Mavissakalian, M | 3 |
| Glitz, D | 1 |
| Raj, AB | 2 |
| Sheehan, KH | 2 |
| Soto, S | 3 |
| Lepola, U | 1 |
| Jolkkonen, J | 1 |
| Rimón, R | 1 |
| Riekkinen, P | 1 |
| Marazziti, D | 1 |
| Placidi, GF | 1 |
| Cassano, GB | 1 |
| Terashima, Y | 1 |
| Ichikawa, T | 1 |
| Suzuki, T | 1 |
| Koizumi, J | 1 |
| Sunderland, G | 1 |
| Friedman, S | 1 |
| Rosenblum, LA | 1 |
| Mavissakalian, MR | 1 |
| Perel, JM | 1 |
| Kahn, RS | 1 |
| Cahn, W | 1 |
| van Praag, HM | 1 |
| Noyes, R | 2 |
| Garvey, MJ | 2 |
| Cook, BL | 1 |
| Samuelson, L | 1 |
| Hollander, E | 1 |
| Fairbanks, J | 1 |
| Decaria, C | 1 |
| Telch, M | 1 |
| Ciccone, PE | 2 |
| Mellerup, ET | 1 |
| Hansen, HJ | 1 |
| Langemark, M | 1 |
| Loldrup, D | 1 |
| Plenge, P | 1 |
| Freedman, AM | 1 |
| Scrignar, CB | 1 |
| Lee, M | 1 |
| Ross, DC | 1 |
| Cohen, P | 1 |
| Pecknold, JC | 2 |
| Yellowlees, PM | 1 |
| Lelliott, P | 1 |
| Marks, I | 1 |
| Eppel, AB | 1 |
| Davidson, J | 1 |
| Pelton, S | 1 |
| Harrison, WM | 2 |
| Goetz, DM | 1 |
| Aronson, TA | 1 |
| Modigh, K | 1 |
| Beitman, BD | 1 |
| Clark, L | 1 |
| Sverd, J | 1 |
| Otakpor, AN | 1 |
| Faludi, G | 1 |
| Kecskeméty, P | 1 |
| Kahn, RJ | 1 |
| McNair, DM | 1 |
| Lipman, RS | 1 |
| Covi, L | 1 |
| Fisher, S | 1 |
| Frankenthaler, LM | 1 |
| Michelson, L | 1 |
| Surman, OS | 1 |
| Williams, J | 1 |
| Strom, TB | 1 |
| Jones, KJ | 1 |
| Coleman, J | 1 |
| Goodman, WK | 1 |
| Rifkin, B | 1 |
| Kinch, M | 1 |
| Aiken, B | 1 |
| Quadrino, LM | 1 |
| Laraia, MT | 1 |
| Ballenger, JC | 1 |
| Howell, EF | 1 |
| Crowe, RR | 1 |
| Chang, H | 1 |
| Fleury, D | 1 |
| Koszychi, D | 1 |
| Quirion, R | 1 |
| Tesar, GE | 1 |
| Goldstein, S | 1 |
| Schneider, LS | 1 |
| Munjack, D | 1 |
| Severson, JA | 1 |
| Palmer, R | 1 |
| Welner, J | 1 |
| Tollefson, GD | 1 |
| Siris, SG | 1 |
| Muskin, PR | 1 |
| Mellman, TA | 1 |
| Davis, GC | 1 |
| Fishman, SM | 1 |
| Carr, DB | 1 |
| Wheatley, D | 1 |
| Lapierre, YD | 1 |
| Itil, TM | 1 |
| Cora, R | 1 |
| Hsu, W | 1 |
| Gig, E | 1 |
| Saletu, B | 1 |
| Koupernik, C | 1 |
| Brattemo, CE | 1 |
| Lassenius, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00005461] | 0 participants | Observational | 1991-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
28 reviews available for imipramine and Anxiety Disorders
| Article | Year |
|---|---|
CNS drug development. Part I: The early period of CNS drugs.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Central | 2010 |
Treating generalized anxiety disorder.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzo | 2003 |
Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Australia; Cost-Benefit Analysis; Cyclohexanols | 2004 |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis.
Topics: Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Female; Humans; Imipramine; Male; Paroxetin | 2005 |
[Pharmacotherapy for the treatment of anxiety disorders in children and adolescents: a sistematic review].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Di | 2007 |
Newer uses for older psychotropic medications.
Topics: Adrenergic beta-Antagonists; Agoraphobia; Anxiety Disorders; Bipolar Disorder; Clonidine; Depressive | 1982 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
Changes in the drug treatment of anxiety disorders.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder | 1984 |
Relationship between separation anxiety and panic and agoraphobic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Anxiety, Separation; Child; Clinical Trials as Topic; Fear; F | 1984 |
Biologic tests in psychiatry.
Topics: Anxiety Disorders; Apomorphine; Clonidine; Dexamethasone; Dextroamphetamine; Growth Hormone; Humans; | 1984 |
Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics.
Topics: Adipose Tissue; Adult; Aged; Aging; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorde | 1984 |
Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety.
Topics: Aged; Animals; Anxiety Disorders; Brain; Cardiovascular System; Clinical Trials as Topic; Depressive | 1981 |
Current concepts in psychiatry. Panic attacks and phobias.
Topics: Adolescent; Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Clinical | 1982 |
Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Meth | 1995 |
Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzamides; Clinical Trials as | 1995 |
Strategies for treatment of generalized anxiety in the primary care setting.
Topics: Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive Behavioral Therapy; Combined Modality Thera | 1997 |
Cardiovascular effects of tricyclic antidepressants in childhood asthma: a case series and review.
Topics: Adolescent; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Asthma; B | 1997 |
[Considerations on respective roles of anxiety and depressive disorders in children].
Topics: Anxiety Disorders; Child; Depressive Disorder; Humans; Imipramine | 1991 |
The drug treatment of panic disorder.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Antidepressive Agents, Tricyc | 1991 |
Validation criteria for panic disorder as a nosological entity.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Panic; Psychiatric Status Ra | 1991 |
The changing horizon in the treatment of depression: scientific/clinical publication overview.
Topics: Adolescent; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Dep | 1991 |
A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Combined Modality Therapy; Humans; Imipramine; Panic; Ph | 1991 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria | 1990 |
[Pathogenesis of panic disorders].
Topics: Adolescent; Adult; Anxiety Disorders; Buspirone; Fear; Female; Humans; Imipramine; Male; Panic | 1989 |
Psychopharmacology and psychotherapy in the treatment of anxiety.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trial | 1986 |
Antidepressant drugs in anxiety disorders.
Topics: Antidepressive Agents; Anxiety Disorders; Clomipramine; Humans; Imipramine; Monoamine Oxidase Inhibi | 1987 |
A model of panic and agoraphobic development.
Topics: Agoraphobia; Anxiety Disorders; Autonomic Nervous System; Fear; Humans; Imipramine; Panic; Phobic Di | 1987 |
Panic disorder: response to sodium lactate and treatment with antidepressants.
Topics: Agoraphobia; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Fear; Humans; Imipramine; | 1985 |
75 trials available for imipramine and Anxiety Disorders
| Article | Year |
|---|---|
Predictors of treatment response in anxious-depressed adolescents with school refusal.
Topics: Adolescent; Adolescent Behavior; Antidepressive Agents, Tricyclic; Anxiety Disorders; Child; Cogniti | 2003 |
Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.
Topics: Adaptation, Psychological; Adjustment Disorders; Adrenergic alpha-Antagonists; Adult; Antidepressive | 2008 |
Specific anxiety syndromes: current therapeutic options.
Topics: Agoraphobia; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepin | 1981 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
Treatment of panic disorder with imipramine alone.
Topics: Adult; Agoraphobia; Anxiety Disorders; Attitude to Health; Clinical Trials as Topic; Fear; Female; H | 1984 |
Changes in the drug treatment of anxiety disorders.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder | 1984 |
Relationship between separation anxiety and panic and agoraphobic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Anxiety, Separation; Child; Clinical Trials as Topic; Fear; F | 1984 |
Phenelzine v imipramine in atypical depression. A preliminary report.
Topics: Adolescent; Adult; Anxiety Disorders; Blood Platelets; Clinical Trials as Topic; Depressive Disorder | 1984 |
Psychopharmacologic validation of atypical depression.
Topics: Adolescent; Adult; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1984 |
Differential response patterns to MAO inhibitors and tricyclics.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Depressive Dis | 1984 |
Panic-induced elevation of plasma MHPG levels in phobic-anxious patients. Effects of clonidine and imipramine.
Topics: Adult; Anxiety Disorders; Clonidine; Double-Blind Method; Fear; Female; Glycols; Humans; Imipramine; | 1983 |
Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety.
Topics: Aged; Animals; Anxiety Disorders; Brain; Cardiovascular System; Clinical Trials as Topic; Depressive | 1981 |
Anxiety: differential diagnosis and treatment from a biologic perspective.
Topics: Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Diagnosis, Differential; Diazepam; Double- | 1981 |
Current concepts in psychiatry. Panic attacks and phobias.
Topics: Adolescent; Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Clinical | 1982 |
[Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Imipram | 1982 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; | 1994 |
Imipramine in alopecia areata. A double-blind, placebo-controlled study.
Topics: Adult; Alopecia Areata; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; | 1994 |
Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
Topics: Adult; Aged; Anxiety Disorders; Diazepam; Double-Blind Method; Drug Administration Schedule; Female; | 1993 |
A study comparing paroxetine placebo and imipramine in depressed patients.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depressive Disorder; Dose-Response Relationship, Drug; D | 1993 |
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Me | 1993 |
The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Community | 1996 |
Lactate-induced anxiety after imipramine and diazepam treatment.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Arousal | 1994 |
Paroxetine efficacy in the treatment of generalized anxiety disorder.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorde | 1997 |
Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
Topics: Adult; Aged; Anxiety Disorders; Comorbidity; Depressive Disorder; Drug Administration Schedule; Fema | 1998 |
Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepin | 2000 |
Treatment of school refusal: one-year follow-up.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Anxiety Disorders; Cognitive Behavioral Therapy; Combi | 2001 |
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Analysis of Variance; Anxiety Disorders; Chronic Disease; | 2001 |
Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Diagnosis, | 2002 |
Paroxetine in major depression: a double-blind trial with imipramine and placebo.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; H | 1992 |
Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
Topics: Adult; Age Factors; Alprazolam; Anxiety Disorders; Arousal; Drug Administration Schedule; Female; Hu | 1991 |
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Arousal; Child; Double-Blind Method; Female; Human | 1991 |
A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Arousal; Humans; Imipramine; Panic; Personality Tests; Psychiatric St | 1991 |
Characteristics of panic disorder patients responding to placebo.
Topics: Alprazolam; Anxiety Disorders; Double-Blind Method; Drug Evaluation; Female; Humans; Imipramine; Mal | 1991 |
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; | 1991 |
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipra | 1991 |
Surreptitious drug use by patients in a panic disorder study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Me | 1990 |
How "blind" are double-blind studies?
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle | 1991 |
Pediatric cardiovascular effects of imipramine and desipramine.
Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Desipramine; Double-Blind Method; Electro | 1991 |
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Treatment of panic and agoraphobia. An integrative review.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Bibliographies as Topic; Clinical Tria | 1990 |
Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P | 1990 |
Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
Topics: Adult; Alprazolam; Anxiety Disorders; Double-Blind Method; Humans; Imipramine; Middle Aged; Panic; P | 1990 |
Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects.
Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Administra | 1990 |
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disabi | 1990 |
Patterns of response during placebo treatment of panic disorder.
Topics: Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Fear; Follow-Up Studie | 1990 |
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
Topics: Anxiety Disorders; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Panic; Phenelzine; | 1990 |
Comparative studies of pharmacotherapy for school refusal.
Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double- | 1990 |
Antidepressants, alcohol and psychomotor performance.
Topics: Antidepressive Agents; Anxiety Disorders; Clomipramine; Depressive Disorder; Dose-Response Relations | 1990 |
Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Arousal; Double-Blind Method; Female; Humans; Imi | 1990 |
Triiodothyronine potentiation of tricyclic antidepressant treatment in patients with panic disorder.
Topics: Adult; Anxiety Disorders; Arousal; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipra | 1990 |
Is buspirone effective for panic disorder?
Topics: Adult; Agoraphobia; Anxiety Disorders; Arousal; Buspirone; Double-Blind Method; Fear; Female; Follow | 1990 |
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double- | 1989 |
Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
Topics: Adolescent; Adult; Aged; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Dose-Response Rel | 1989 |
Psychopharmacology and psychotherapy in the treatment of anxiety.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trial | 1986 |
The placebo effect in agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Desensitization, Psychologic; Femal | 1987 |
Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
Topics: Adult; Agoraphobia; Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Combined Modality | 1987 |
Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Topics: Adult; Alprazolam; Analysis of Variance; Anxiety Disorders; Clinical Trials as Topic; Double-Blind M | 1988 |
Forms of atypical depression and their response to antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bupropion; Clinical Trial | 1986 |
Antidepressant specificity in atypical depression.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Double-Bl | 1988 |
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Double-Bli | 1988 |
Overview of the Cross-National Collaborative Panic Study.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Goals; Humans; Imipramin | 1988 |
Generalized anxiety disorders.
Topics: Amitriptyline; Anxiety Disorders; Arousal; Bromazepam; Clinical Trials as Topic; Combined Modality T | 1987 |
A naturalistic study of imipramine in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear; | 1987 |
Recent developments in the treatment of panic disorder.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clinical Tr | 1987 |
The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report.
Topics: Adult; Anxiety Disorders; Buspirone; Fear; Female; Humans; Imipramine; Male; Panic; Placebos | 1988 |
Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.
Topics: Adult; Agoraphobia; Anxiety Disorders; Chlordiazepoxide; Clinical Trials as Topic; Double-Blind Meth | 1986 |
Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
Topics: Adult; Agoraphobia; Anxiety Disorders; Behavior Therapy; Chronic Disease; Clinical Trials as Topic; | 1986 |
Immunological response to stress in agoraphobia and panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear; | 1986 |
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Fear; Humans; Imipramine; Pani | 1986 |
Imipramine in the treatment of panic disorder and its complications.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior Therapy; Clinical Trials | 1985 |
Lactate vulnerability of remitted panic patients.
Topics: Adult; Agoraphobia; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; D | 1985 |
Influence of doctors' and patients' attitudes in the treatment of neurotic illness.
Topics: Amitriptyline; Amobarbital; Anxiety Disorders; Attitude; Chlordiazepoxide; Clinical Trials as Topic; | 1967 |
Galvanic skin responses (GSR) and plethysmographic changes induced by chlorimipramine, imipramine and placebo.
Topics: Adjustment Disorders; Analysis of Variance; Anxiety Disorders; Arousal; Blood Circulation; Clinical | 1974 |
Clinical, toxicological and electroencephalographical effects of a new tricyclic antidepressant, OI-77.
Topics: Adjustment Disorders; Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cerebral Corte | 1972 |
99 other studies available for imipramine and Anxiety Disorders
| Article | Year |
|---|---|
NCS-1 deficiency causes anxiety and depressive-like behavior with impaired non-aversive memory in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Avoidance Learnin | 2014 |
Minocycline does not evoke anxiolytic and antidepressant-like effects in C57BL/6 mice.
Topics: Animals; Anti-Anxiety Agents; Anti-Bacterial Agents; Antidepressive Agents; Anxiety Disorders; Depre | 2016 |
Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety Disorders; Behavior, Animal; Brain Isc | 2009 |
Trait anxiety and defensive functioning in relation to antidepressant treatment outcome.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Female; Huma | 2009 |
Anxiety in youth.
Topics: Adolescent; Anxiety Disorders; Child; Comorbidity; Cross-Sectional Studies; Humans; Imipramine; Impl | 2010 |
Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.
Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressi | 2012 |
[Effect of antiasthenic drug ladasten on the level of cytokines and behavior in experimental model of anxious depression in C57BL/6 male mice].
Topics: Adamantane; Animals; Antidepressive Agents; Anxiety Disorders; Behavior, Animal; Depression; Disease | 2011 |
[Significance of imipramine in the medico-psychopedagogical reduction of depressive behavior in the form of anxiety and inhibition].
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Imipramine; Psychopharmacology | 1961 |
[Post-imipramine anxiety. Its phenomenology-its treatment].
Topics: Anxiety; Anxiety Disorders; Humans; Imipramine; Psychopharmacology | 1961 |
EFFECTS OF IMIPRAMINE UPON VARIOUS MENTAL SYNDROMES IN AMBULATORY TREATMENT.
Topics: Anxiety; Anxiety Disorders; Autonomic Nervous System Diseases; Dementia; Depression; Humans; Imipram | 1963 |
TREATMENT OF CHRONIC TENSION HEADACHE.
Topics: Amitriptyline; Amobarbital; Anxiety; Anxiety Disorders; Biomedical Research; Chlordiazepoxide; Diaze | 1964 |
[PECULIARITIES OF THE PHOTOERYTHEMIC SKIN REACTION IN PATIENTS WITH MANIC-DEPRESSIVE CONDITIONS AND ITS DYNAMICS DURING THE COURSE OF TREATMENT].
Topics: Anxiety; Anxiety Disorders; Bipolar Disorder; Chlorpromazine; Depression; Depressive Disorder; Depre | 1963 |
[BARBAMYL-TOFRANIL TEST IN THE EVALUATION OF THE DEPRESSIVE STATE].
Topics: Amobarbital; Anxiety; Anxiety Disorders; Bipolar Disorder; Delirium; Delusions; Depression; Depressi | 1963 |
DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Chlorpromazine; Imipramine; Parasympatholytics; Pla | 1964 |
[PSYCHOPHARMACOLOGICAL EXPERIENCES WITH IMIPRAMINE, WITH SPECIAL REFERENCE TO LEONHARD'S CLASSIFICATION OF ENDOGENOUS PSYCHOSES].
Topics: Anxiety; Anxiety Disorders; Bipolar Disorder; Depression; Depressive Disorder; Drug Therapy; Humans; | 1964 |
Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Aggression; Animals; Anti-Anxiety Age | 2008 |
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive A | 2007 |
Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.
Topics: Adolescent; Adult; Anxiety Disorders; Blood Platelets; Catecholamines; Clonidine; Dopamine; Epinephr | 1984 |
A re-examination of the clinical effects of imipramine and amitriptyline in depressive illness.
Topics: Amitriptyline; Anxiety Disorders; Delayed-Action Preparations; Depressive Disorder; Double-Blind Met | 1980 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven | 1984 |
A clinical report of thymoleptic-responsive atypical paranoid psychoses.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Delusions; Diagnosis, Differential; | 1983 |
Panic disorder.
Topics: Adolescent; Adult; Anxiety Disorders; Desipramine; Diagnosis, Differential; Family Practice; Fear; F | 1983 |
Seminal emission induced by tricyclic antidepressant.
Topics: Anxiety Disorders; Defecation; Depressive Disorder; Desipramine; Double-Blind Method; Ejaculation; H | 1984 |
Dexamethasone suppression test in patients with panic disorder and secondary depression.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Dexamethasone; Fear; Female; Humans; Hydrocortisone; | 1984 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde | 1984 |
Lactate provocation of panic attacks. I. Clinical and behavioral findings.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clonidine; Desipramine; Fear; Female; Humans; Imipramine; Lac | 1984 |
[Psychotropic drugs for children].
Topics: Amitriptyline; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Ce | 1981 |
Treatment of agoraphobia and panic attacks.
Topics: Agoraphobia; Anxiety Disorders; Behavior Therapy; Double-Blind Method; Fear; Humans; Imipramine; Pan | 1983 |
Treatment of flashbacks by imipramine.
Topics: Accidents, Occupational; Anxiety Disorders; Humans; Imipramine; Male; Panic | 1983 |
Panic.
Topics: Adult; Anxiety Disorders; Cardiovascular Diseases; Endocrine System Diseases; Fear; Female; Humans; | 1982 |
The dexamethasone suppression test in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Depressive Disorder; Dexamethasone; Diagnosis, Differential; | 1982 |
Response of panic disorder and resistance of depression to imipramine.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Imipramine; Male; Panic | 1982 |
[Antidepressant drugs and anxiety (author's transl)].
Topics: Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Stimulation, Chem | 1982 |
Blockade by imipramine or desipramine of panic induced by sodium lactate.
Topics: Anxiety Disorders; Desipramine; Fear; Humans; Imipramine; Lactates; Panic | 1981 |
The clinical characteristics and treatment of atypical depression.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Desipramine; Fatigue; Female; Humans; Imipramine; Mal | 1981 |
Correct titration of non-drugs and some other methodological issues.
Topics: Administration, Oral; Amitriptyline; Anxiety Disorders; Benperidol; Depressive Disorder; Dose-Respon | 1994 |
Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets.
Topics: Adult; Anxiety Disorders; Arousal; Blood Platelets; Depressive Disorder; Female; Humans; Hydrocortis | 1994 |
Sexual dysfunction during antidepressant treatment.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depressive Disorder; | 1993 |
New perspectives in the management of depression. Symposium highlights from ECNP, Venice, September 1995.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depressive Disorder; Human | 1996 |
Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment.
Topics: Adult; Agoraphobia; Anxiety Disorders; Binding Sites; Blood Platelets; Depressive Disorder; Humans; | 1996 |
Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressiv | 1998 |
Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Clomipramine; Depressive Disorder, Major; Fluox | 2000 |
Therapeutic effects of imipramine are counteracted by its metabolite, desipramine, in patients with generalized anxiety disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety Disorders; Arrhythmia, Sinus; Blood Pressure; Desiprami | 2000 |
Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use?
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Double-Blind Method | 2001 |
Benzodiazepine discontinuation in generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Imipramine; Long-Term Ca | 2002 |
An operant counting scale for children: A preliminary methodological psychoactive-drug case study.
Topics: Adolescent; Aggression; Anxiety Disorders; Child; Child Behavior Disorders; Dependency, Psychologica | 1975 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; | 1992 |
[Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam].
Topics: Adult; Anxiety Disorders; Clonazepam; Depression; Female; Humans; Imipramine; Lactates; Lactic Acid; | 1992 |
Drug-related alopecia in patients treated with tricyclic antidepressants.
Topics: Adult; Alopecia; Antidepressive Agents, Tricyclic; Anxiety Disorders; Child; Child Behavior Disorder | 1991 |
Simultaneous prepubertal onset of panic disorder, night terrors, and somnambulism.
Topics: Anxiety Disorders; Child; Humans; Imipramine; Life Change Events; Male; Panic; Personality Developme | 1991 |
Clonidine-imipramine therapy.
Topics: Adult; Anxiety Disorders; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Female | 1991 |
Exacerbation of panic disorder in a woman treated with trimethoprim-sulfamethoxazole.
Topics: Alprazolam; Anxiety Disorders; Drug Therapy, Combination; Female; Humans; Imipramine; Middle Aged; P | 1991 |
Pharmacologic approach to sleep panic attacks.
Topics: Adult; Anxiety Disorders; Fear; Female; Humans; Imipramine; Lithium; Lithium Carbonate; Lorazepam; P | 1990 |
The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients.
Topics: Adult; Agoraphobia; Ambulatory Care; Anxiety Disorders; Carbon Dioxide; Female; Humans; Imipramine; | 1990 |
Imipramine treatment of panic disorder during pregnancy.
Topics: Adult; Anxiety Disorders; Female; Humans; Imipramine; Panic; Pregnancy; Pregnancy Complications; Pre | 1990 |
Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Electromyography; Epinephrine; Female; Heart Rate; Hu | 1990 |
Heart rate and blood pressure: significance of the law of initial values.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Blood Pressure; Depressive Disorder; Female; Heart Rate; | 1990 |
Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
Topics: Adolescent; Adult; Agoraphobia; Anxiety Disorders; Behavior Therapy; Combined Modality Therapy; Fear | 1990 |
Increased serum total cholesterol to HDL-cholesterol ratio after imipramine.
Topics: Adult; Anxiety Disorders; Cholesterol; Cholesterol, HDL; Depressive Disorder; Diazepam; Fear; Female | 1990 |
Schizophrenia, panic attacks, and antidepressants.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Drug Therapy, Combination; Fear; Female; Humans; Imi | 1989 |
Lack of specificity of reduced platelet imipramine binding in different psychiatric conditions.
Topics: Adolescent; Adult; Anxiety Disorders; Blood Platelets; Bulimia; Humans; Imipramine; Mental Disorders | 1989 |
An adult case of psychogenic alopecia universalis.
Topics: Adult; Alopecia; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Job Satisfaction; Male; | 1989 |
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates.
Topics: Alprazolam; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Fear; Homing | 1989 |
Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
Topics: Adult; Agoraphobia; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Anxiety Disorders; Ap | 1989 |
Symptoms and treatment responses of generalized anxiety disorder patients with high versus low levels of cardiovascular complaints.
Topics: Adult; Alprazolam; Anxiety Disorders; Female; Heart Diseases; Heart Rate; Humans; Imipramine; Male; | 1989 |
Pharmacological dissection of panic and depersonalization.
Topics: Adolescent; Alprazolam; Anxiety Disorders; Depersonalization; Fear; Female; Fluoxetine; Humans; Imip | 1989 |
Use of medication and in vivo exposure in volunteers for panic disorder research.
Topics: Adult; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; | 1989 |
Imipramine treatment and increased serum cholesterol levels.
Topics: Adult; Anxiety Disorders; Cholesterol; Fear; Female; Humans; Imipramine; Male; Panic; Retrospective | 1989 |
Action of imipramine and alprazolam in panic disorder.
Topics: Alprazolam; Anxiety Disorders; Fear; Humans; Imipramine; Panic; Receptors, Adrenergic; Receptors, GA | 1988 |
Platelet 3H-imipramine binding in psychogenic pain patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Blood Platelets; Carrier Proteins; De | 1988 |
Postpanic anxiety disorder: diagnosis and treatment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen | 1986 |
How antipanic drugs might work.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Im | 1986 |
Behavioural and combined therapy in panic states.
Topics: Agoraphobia; Anxiety Disorders; Behavior Therapy; Cognition; Combined Modality Therapy; Desensitizat | 1987 |
The treatment of psychiatric disorders in patients with chronic airways obstruction.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Female; Humans; | 1987 |
The cause and treatment of agoraphobia.
Topics: Agoraphobia; Anxiety Disorders; Arousal; Desensitization, Psychologic; Humans; Imipramine; Life Chan | 1988 |
Imipramine and clonazepam for panic disorder.
Topics: Anxiety Disorders; Clonazepam; Depressive Disorder; Drug Therapy, Combination; Fear; Humans; Imipram | 1989 |
Relationship between anxiety and depression.
Topics: Anxiety Disorders; Depressive Disorder; Fear; Humans; Imipramine; Panic | 1989 |
Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Pressure; Brain; Female; Humans; Imipramine; Male; Meth | 1985 |
The jitteriness syndrome in panic disorder patients treated with antidepressants.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Diso | 1988 |
Inadvertent imipramine challenge in panic.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Imipramine; Locus Coeruleus; Pa | 1988 |
Performance anxiety and panic disorder.
Topics: Anxiety Disorders; Fear; Humans; Imipramine; Panic | 1988 |
Imipramine treatment of panic disorder in a boy with Tourette's syndrome.
Topics: Age Factors; Anxiety Disorders; Child, Preschool; Fear; Humans; Imipramine; Male; Panic; Phobic Diso | 1988 |
A prospective study of panic disorder in a Nigerian psychiatric out-patient population.
Topics: Adolescent; Adult; Anxiety Disorders; Fear; Female; Humans; Imipramine; Life Change Events; Male; Ma | 1987 |
Melipramine treatment of panic disease.
Topics: Adult; Anxiety Disorders; Fear; Female; Humans; Imipramine; Injections; Male; Middle Aged; Panic | 1987 |
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Female; | 1987 |
Anxiety reconceptualized. Gleaning from pharmacological dissection--early experience with imipramine and anxiety.
Topics: Agoraphobia; Anxiety Disorders; Anxiety, Separation; Arousal; Behavior Therapy; Combined Modality Th | 1987 |
Panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Animals; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Diagnosis, Differ | 1986 |
Platelet imipramine binding in patients with panic disorder and major familial depression.
Topics: Adult; Anxiety Disorders; Blood Platelets; Depressive Disorder; Fear; Female; Humans; Imipramine; Ma | 1987 |
Successful use of clonazepam in patients with treatment-resistant panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clonazepam; D | 1986 |
Sequential treatment of panic disorder with alprazolam and imipramine.
Topics: Alprazolam; Anxiety Disorders; Drug Administration Schedule; Drug Therapy, Combination; Fear; Humans | 1986 |
Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Platelets; Female; Humans; Imipramine; Kinetics; Male; | 1987 |
Efficacy of imipramine and chlordiazepoxide in depressive and anxiety disorders questioned.
Topics: Ambulatory Care; Anxiety Disorders; Chlordiazepoxide; Depressive Disorder; Humans; Imipramine; Psych | 1987 |
Occurrence of myoclonus in patients treated with cyclic antidepressants.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Fe | 1987 |
Panics, prolapse, and PVCs.
Topics: Adult; Anxiety Disorders; Arrhythmias, Cardiac; Diagnosis, Differential; Fear; Female; Humans; Imipr | 1985 |
Combat-related flashbacks in posttraumatic stress disorder: phenomenology and similarity to panic attacks.
Topics: Adult; Affect; Anxiety Disorders; Combat Disorders; Delusions; Fear; Hallucinations; Humans; Imipram | 1985 |
Thyroid indices in panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Fear; Female; Humans; Imipramine; Male; Middl | 1985 |
Endogenomorphic depression. A conceptual and terminological revision.
Topics: Adjustment Disorders; Anxiety Disorders; Bipolar Disorder; Depression; Factor Analysis, Statistical; | 1974 |
Chemotherapy in child psychiatry.
Topics: Amphetamine; Anxiety Disorders; Child; Child Psychiatry; Child, Preschool; Chlordiazepoxide; Diazepa | 1972 |
Differential changes on variables of depression as measured objectively and subjectively.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Female; Humans; Imipramine; Male; Mental Disorders; | 1965 |